Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

The global Kaposi’s Sarcoma market is expanding due to the HIV/AIDS prevalence, improved oncology infrastructure, and advancements in targeted and immunotherapeutic drugs. Kaposi’s Sarcoma, a tumor ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...

There is a need to address wrong theological teachings that prescribe only to miracle cure of HIV/Aids and denigrate science ...

A new study offers good news from Uganda — although the cuts in U.S. aid cast a shadow over the reduction in deaths of ...

The year 2026 marks an important milestone with only 5 years left for world leaders to deliver on the promise of ending AIDS ...

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

Over 10,000 Floridians are losing HIV medication due to a supposed shortfall in the state budget. Democratic Party Chair ...

Following the wave of federal grant terminations in March, the San Diego-based Prebys Foundation announced $7 million in medical research grants — emergency support for biomedical research at seven ...